A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer

ConclusionER −/PR+ tumors have more aggressive pathological characteristics and more unfavorable clinical features than ER+ tumors. ET can reduce the LRR and mortality rates in ER−/PR+ patients. Postmenopausal and age ≥ 55 years ER−/PR+ patients can benefit from ET.

http://link.springer.com/10.1007/s10549-023-06964-6

Source: Breast Cancer Research and Treatment - June 6, 2023 Category: Cancer & Oncology Source Type: research